Science
Mechanism of Action
This extract operates through the modulation of the cutaneous endocannabinoid system (ECS), specifically inhibiting the NF-κB pathway to downregulate pro-inflammatory cytokines. It provides robust antioxidant protection via polyphenols such as isoquercetin and ferulic acid while demonstrating antimicrobial properties and regulating sebum production through direct interaction with sebocytes.
Research
Clinical Evidence
Medium confidence1%
Key findings
- 01 In vitro human keratinocyte analysis confirming downregulation of inflammation-related genes.
- 02 In vivo rabbit models showing accelerated lesion healing at concentrations between 0.02% and 0.08%.
- 03 MDPI study (2026) demonstrating significant antimicrobial and antifungal activity at 0.5% to 4.0% in protective films.
Transparency
Dusting Analysis
Due to its high marketing value and regulatory complexities, many products include this ingredient at trace levels below 0.02%, which is insufficient to trigger its biological mechanisms for lesion healing or microbial inhibition.
The Formula
Formulation
Stability
Highly sensitive to environmental degradation; exposure to UV light, oxygen, or temperatures exceeding 66°C can compromise efficacy. It requires cool-down phase incorporation to prevent oxidation.
Synergies
- Squalane
- Ceramides
- Vitamin E
Conflicts
- Strong acids (pH < 4.5)
- Strong bases (pH > 8.0)
- High-heat processing
Safety
Safety Profile
THC content must be strictly controlled (typically <0.2-0.3%). Prohibited for cosmetic use in Canada; FDA monitors for therapeutic over-claims.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-performance botanical for inflammatory control and barrier support, provided it is formulated within a stable pH range and at therapeutic concentrations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources